Magnetic resonance imaging(MRI)is one of the most widely used diagnostic techniques.Iron oxide nanoparticles,as a promising kind of contrast agents,have attracted intense research interest due to their low toxicity an...Magnetic resonance imaging(MRI)is one of the most widely used diagnostic techniques.Iron oxide nanoparticles,as a promising kind of contrast agents,have attracted intense research interest due to their low toxicity and superparamagnetism.However,it is still a great challenge to prepare ideal iron oxide based contrast agents with high uniformity,excellent water solubility and biocompatibility.In this paper,a novel water-soluble polymer ligand pentaerythritol tetrakis 3-mercaptopropionate-poly(N-vinyl-2-pyrrolidone)(PTMP-PVP)was used as a capping reagent to prepare iron oxide nanoparticles MIONs@PTMP-PVP through one-step co-precipitation of iron precursors in aqueous solution at 100℃.The obtained nanoparticles MIONs@PTMP-PVP had a small size and narrow size distribution,and they were found to be biocompatible as determined through CCK-8 assay and histology analysis.In vivo MRI study demonstrated that the obtained MIONs@PTMP-PVP can be potentially used as an effective T_(2)-weighted MRI contrast agent.展开更多
Cancer has been recognized as one of the leading causes of mortality for decades.Magnetic resonance imaging(MRI)is a powerful imaging technology that has been widely applied in tumor diagnosis.Herein,we report the syn...Cancer has been recognized as one of the leading causes of mortality for decades.Magnetic resonance imaging(MRI)is a powerful imaging technology that has been widely applied in tumor diagnosis.Herein,we report the synthesis of magnetic iron oxide nanoparticles(MIONs)functionalized with multidentate thioether polymer ligand pentaerythritol tetrakis 3-mercaptopropionate-poly(methacrylic acid)(PTMPPMAA).Cytotoxicity assessment via the CCK-8 assay confirmed the low toxicity of the nanoparticles.MRI results showed excellent negative contrast enhancement.Bio-distribution study indicated gradual excretion of the nanoparticles.These MIONs@PTMP-PMAA exhibit strong negative contrast enhancement and present great potential as T_(2)-weighted contrast agents for MRI.展开更多
基金financially supported by the International Cooperation Program from the Ministry of Science and Technology of Hubei Province(No.2023EHA069)Shenzhen Science and Technology Program(No.JCYJ20230807143702005)National Foreign Experts Program(No.G2022027015L)。
文摘Magnetic resonance imaging(MRI)is one of the most widely used diagnostic techniques.Iron oxide nanoparticles,as a promising kind of contrast agents,have attracted intense research interest due to their low toxicity and superparamagnetism.However,it is still a great challenge to prepare ideal iron oxide based contrast agents with high uniformity,excellent water solubility and biocompatibility.In this paper,a novel water-soluble polymer ligand pentaerythritol tetrakis 3-mercaptopropionate-poly(N-vinyl-2-pyrrolidone)(PTMP-PVP)was used as a capping reagent to prepare iron oxide nanoparticles MIONs@PTMP-PVP through one-step co-precipitation of iron precursors in aqueous solution at 100℃.The obtained nanoparticles MIONs@PTMP-PVP had a small size and narrow size distribution,and they were found to be biocompatible as determined through CCK-8 assay and histology analysis.In vivo MRI study demonstrated that the obtained MIONs@PTMP-PVP can be potentially used as an effective T_(2)-weighted MRI contrast agent.
基金financially supported by the International Cooperation Program of the Ministry of Science and Technology of Hubei Province(No.2023EHA069)Shenzhen Science and Technology Program(No.JCYJ20230807143702005)+1 种基金National Foreign Experts Program(No.G2022027015L)the National Natural Science Foundation of China(No.82302265).
文摘Cancer has been recognized as one of the leading causes of mortality for decades.Magnetic resonance imaging(MRI)is a powerful imaging technology that has been widely applied in tumor diagnosis.Herein,we report the synthesis of magnetic iron oxide nanoparticles(MIONs)functionalized with multidentate thioether polymer ligand pentaerythritol tetrakis 3-mercaptopropionate-poly(methacrylic acid)(PTMPPMAA).Cytotoxicity assessment via the CCK-8 assay confirmed the low toxicity of the nanoparticles.MRI results showed excellent negative contrast enhancement.Bio-distribution study indicated gradual excretion of the nanoparticles.These MIONs@PTMP-PMAA exhibit strong negative contrast enhancement and present great potential as T_(2)-weighted contrast agents for MRI.
